How were the American College of Rheumatology vasculitis treatment guidelines developed?

How were the American College of Rheumatology vasculitis treatment guidelines developed?

Introducing the 2021 ACR/VF Vasculitis Clinical Practice Guidelines Part 1Подробнее

Introducing the 2021 ACR/VF Vasculitis Clinical Practice Guidelines Part 1

Report from EULAR Advances in Research and TreatmentsПодробнее

Report from EULAR Advances in Research and Treatments

Insights into Vasculitis: A Rheumatology Journey | Dr. Sebastian Sattui | Premed eShadowing Ep. 107Подробнее

Insights into Vasculitis: A Rheumatology Journey | Dr. Sebastian Sattui | Premed eShadowing Ep. 107

American College of Rheumatology, Eric Ruderman, MDПодробнее

American College of Rheumatology, Eric Ruderman, MD

Vaccines and Vasculitis Update 2023Подробнее

Vaccines and Vasculitis Update 2023

2024 ACR Guideline: Screening, Treatment, and Management of Lupus NephritisПодробнее

2024 ACR Guideline: Screening, Treatment, and Management of Lupus Nephritis

Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis with Dr. Peter MerkelПодробнее

Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis with Dr. Peter Merkel

Introducing the 2021 ACR/VF Vasculitis Clinical Practice Guidelines Part 2: Q&AПодробнее

Introducing the 2021 ACR/VF Vasculitis Clinical Practice Guidelines Part 2: Q&A

Part 1: Best of the American College of Rheumatology 2020Подробнее

Part 1: Best of the American College of Rheumatology 2020

ACR VF Guideline Langford Session 2Подробнее

ACR VF Guideline Langford Session 2

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and TreatmentПодробнее

KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment

Get to Know the Association of Rheumatology Professionals (ARP)Подробнее

Get to Know the Association of Rheumatology Professionals (ARP)

Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur KavanaughПодробнее

Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh

CanVasc Consensus Recommendations for the Management of ANCA-associated Vasculitis: Arielle MendelПодробнее

CanVasc Consensus Recommendations for the Management of ANCA-associated Vasculitis: Arielle Mendel

Treat to Target in VasculitisПодробнее

Treat to Target in Vasculitis

Expert Recommendations from ACR on Psoriatic Arthritis, Ankylosing Spondylitis, Lupus, Vasculitis.Подробнее

Expert Recommendations from ACR on Psoriatic Arthritis, Ankylosing Spondylitis, Lupus, Vasculitis.

Vasculitis, Vaccinations, and BeyondПодробнее

Vasculitis, Vaccinations, and Beyond

Why In-Person Education Is BetterПодробнее

Why In-Person Education Is Better

1/13/17 Grand Rounds: Diet, Drugs and Steel: Rheumatology Update for the InternistПодробнее

1/13/17 Grand Rounds: Diet, Drugs and Steel: Rheumatology Update for the Internist